Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma

Neoplasia(2021)10.1016/j.neo.2021.06.005Source: DataRank Database

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma is a research paper published in Neoplasia (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.55)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Sabine Hellwig ORCID,David A. Nix ORCID,Mary P. Bronner ORCID,Alun Thomas ORCID,Carrie L. Fuertes ORCID

Live enrichment

PubMed:34298235 PMC:PMC8322473 OpenAlex:https://openalex.org/W3184042668

National Center for Advancing Translational Sciences

Grant: UL1TR001067

National Cancer Institute

Grant: P30CA042014

National Cancer Institute

Grant: R37CA246183

NCATS NIH HHS

Grant: UL1 TR002538

National Institutes of Health

Grant: 3P30CA042014-30S2

Cancer Center Support Grant

National Institutes of Health

Grant: 3UL1TR001067-04S2

University of Utah Center for Clinical and Translational Science

National Institutes of Health

Grant: 5R37CA246183-03

Circulating Cell-Free DNA as a Personalized Biomarker to Diagnose and Monitor Glioblastoma

National Institutes of Health

FWCI

0.55

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.neo.2021.06.005

publisherhttps://doi.org/10.1016/j.neo.2021.06.005

publisherhttps://api.elsevier.com/content/article/PII:S1476558621000452?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1476558621000452?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34298235

Fields of Study

Cancer Genomics and DiagnosticsPancreatic and Hepatic Oncology ResearchSingle-cell and spatial transcriptomics0301 basic medicine03 medical and health sciences

MeSH Terms

Circulating Tumor DNAAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPancreatic NeoplasmsPrognosisBiomarkers, TumorSequence Analysis, DNACarcinoma, Pancreatic DuctalHigh-Throughput Nucleotide Sequencing

Keywords

KRASBiomarkerBiologyLiquid biopsyDNA sequencingOncologyAdenocarcinomaGeneCancer researchInternal medicineCancerMedicineMutationGeneticsPancreatic Ductal AdenocarcinomaNext-generation SequencingCell-free DnaCirculating Tumor DnaMaleNeoplasms. Tumors. Oncology. Including cancer and carcinogensHigh-Throughput Nucleotide SequencingSequence Analysis, DNAMiddle AgedPrognosisPancreatic NeoplasmsBiomarkers, TumorHumansFemaleRC254-282Original ResearchAgedCarcinoma, Pancreatic DuctalFollow-Up Studies

Sustainable Development Goals

SDG 0: Good health and well-being

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma

FAIR Checklist

Authors (11)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)